Clinical Trials Directory

Trials / Completed

CompletedNCT02823340

Fractionated Microneedle Radiofrequency for Treatment of Primary Axillary Hyperhidrosis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
20 (actual)
Sponsor
Xijing Hospital · Academic / Other
Sex
All
Age
18 Years – 40 Years
Healthy volunteers
Not accepted

Summary

Twenty patients with PAH had 1 session of Fractionated microneedle radiofrequency treatment. Clinical improvement was evaluated using a Hyperhidrosis Disease Severity Scale (HDSS) and photographs were taken using the starch-iodine test at every visit and 4 weeks, 8 weeks, and 24 weeks after the treatment. Skin biopsies were obtained from 3 of the enrolled patients before and after treatment. The satisfaction and adverse reactions of the research participants were recorded at every follow-up visit.

Detailed description

Hyperhidrosis Disease Severity Scale (HDSS)Score = 1 My sweating is never noticeable and never interferes with my daily activitiesScore = 2 My sweating is tolerable but sometimes interferes with my daily activitiesScore = 3 My sweating is barely tolerable and frequently interferes with my daily activitiesScore = 4 My sweating is intolerable and always interferes with my daily activities

Conditions

Interventions

TypeNameDescription
DEVICEFractional microneedle RF(United, Peninsula Medical, China)

Timeline

Start date
2016-03-01
Primary completion
2017-12-01
Completion
2017-12-31
First posted
2016-07-06
Last updated
2021-03-15

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT02823340. Inclusion in this directory is not an endorsement.